trial · primary record
Carboplatin
FIGO Stage IVA Ovarian Cancer
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2027-01-05 |
| Primary endpoint | Incidence of treatment-related toxicities according to National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) guidelines |
| Registry ID | NCT01970722 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:47.013Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01970722
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.